Activation of the bile acid pathway promotes tumorigenesis in clear cell renal cell carcinoma

被引：0
|
作者：
Riscal, Romain [1 ]
Gardner, Sarah [1 ]
Carens, Madeleine [1 ]
Mesaros, Clementina [1 ]
Xu, Jimmy [1 ]
Coffey, Nate [1 ]
Davis, Leah [1 ]
Vogt, Austin [1 ]
Olia, Adam [1 ]
Finan, Jennifer [1 ]
Godfrey, Jason [1 ]
Blair, Ian [1 ]
Keith, Brian [1 ]
Marmorstein, Ronen [1 ]
Skuli, Nicolas [1 ]
Simon, Celeste [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
CANCER RESEARCH | 2023年 / 83卷 / 16期
关键词：
D O I：
10.1158/1538-7445.KIDNEY23-B008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B008
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Difference between RAT and clear cell papillary renal cell carcinoma/clear renal cell carcinoma
    Michal, Michal
    Hes, Ondrej
    Kuroda, Naoto
    Kazakov, Dmitry V.
    Hora, Milan
    VIRCHOWS ARCHIV, 2009, 454 (06) : 719 - 719
  • [42] Inactivation of the AMPK-GATA3-ECHS1 Pathway Induces Fatty Acid Synthesis That Promotes Clear Cell Renal Cell Carcinoma Growth
    Qu, Yuan-Yuan
    Zhao, Rui
    Zhang, Hai-Liang
    Zhou, Qian
    Xu, Fu-Jiang
    Zhang, Xuan
    Xu, Wen-Hao
    Shao, Ning
    Zhou, Shu-Xian
    Dai, Bo
    Zhu, Yao
    Shi, Guo-Hai
    Shen, Yi-Jun
    Zhu, Yi-Ping
    Han, Cheng-Tao
    Chang, Kun
    Lin, Yan
    Zang, Wei-Dong
    Xu, Wei
    Ye, Ding-Wei
    Zhao, Shi-Min
    Zhao, Jian-Yuan
    CANCER RESEARCH, 2020, 80 (02) : 319 - 333
  • [43] Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma
    Lopez, Jose I.
    Errarte, Pei
    Erramuzpe, Asier
    Guarch, Rosa
    Cortes, Jesus M.
    Angulo, Javier C.
    Pulido, Rafael
    Irazusta, Jon
    Llarena, Roberto
    Larrinaga, Gorka
    HUMAN PATHOLOGY, 2016, 54 : 100 - 105
  • [44] Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma
    Zhou Jiangqiao
    Qiu Tao
    Chen Zhongbao
    Ma Xiaoxiong
    Zhang Long
    Zou Jilin
    Wang Tianyu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 511 (01) : 165 - 172
  • [45] Defective NMD promotes aberrant intron retention in clear cell renal cell carcinoma
    Zhou, Mi
    Giri, Gilbert
    Kim, William Y.
    Dominguez, Daniel
    CANCER RESEARCH, 2024, 84 (06)
  • [46] FOXD1 promotes stromal investment in clear cell renal cell carcinoma
    Bond, Kyle H.
    Fetting, Jennifer
    Gupta, Ashwani
    Duarte, Christine W.
    Karolak, Michele
    Congdon, Clare B.
    Emery, Ivette
    Hainmhire, Eoghainin O.
    Humphreys, Benjamin D.
    Oxburgh, Leif
    CANCER RESEARCH, 2018, 78 (13)
  • [47] Activation of the WNT signaling pathway correlates with innate resistance to immune checkpoint therapies in clear cell renal cell carcinoma
    Sheng, X.
    Gong, F.
    Bai, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S577 - S577
  • [48] Clear Cell Papillary Renal Cell Carcinoma (CCPAP): A Distinct Entity or a Variant of Clear Cell Renal Cell Carcinoma?
    Rohan, S. M.
    Dudas, M. E.
    Gopalan, A.
    Fine, S. W.
    Reuter, V. E.
    Tickoo, S. K.
    LABORATORY INVESTIGATION, 2009, 89 : 191A - 191A
  • [49] Clear Cell Papillary Renal Cell Carcinoma (CCPAP): A Distinct Entity or a Variant of Clear Cell Renal Cell Carcinoma?
    Rohan, S. M.
    Dudas, M. E.
    Gopalan, A.
    Fine, S. W.
    Reuter, V. E.
    Tickoo, S. K.
    MODERN PATHOLOGY, 2009, 22 : 191A - 191A
  • [50] ZNF692 promotes the migration and response to immunotherapy of clear cell renal cell carcinoma cells by targeting metabolic pathway
    Liu, Yuming
    Zeng, Dehua
    Gao, Yunzhen
    DISCOVER ONCOLOGY, 2024, 15 (01)
12345